BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37620791)

  • 1. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
    Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
    BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.
    Popp I; Rau S; Hintz M; Schneider J; Bilger A; Fennell JT; Heiland DH; Rothe T; Egger K; Nieder C; Urbach H; Grosu AL
    Cancer; 2020 Jun; 126(11):2694-2703. PubMed ID: 32142171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
    Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
    BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
    Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
    J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
    Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
    Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
    Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
    Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
    Kim Y; Kim SH; Lee JH; Kang DG
    Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on different doses and fractionated radiotherapies for multiple brain metastases of non-EGFR mutant lung adenocarcinoma.
    Liu H; Xu X; Wang J; Wang W; Ma C; Sun T; Shao Q
    Ann Palliat Med; 2020 Jul; 9(4):2003-2012. PubMed ID: 32692247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.
    Popp I; Grosu AL; Fennell JT; Fischer M; Baltas D; Wiehle R
    Strahlenther Onkol; 2022 Jun; 198(6):537-546. PubMed ID: 35357511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study.
    Ni M; Jiang A; Liu W; Sheng Y; Zeng H; Liu N; Gao Q; Wang Y; Yu J; Yuan S
    Radiat Oncol; 2020 Mar; 15(1):70. PubMed ID: 32213185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
    Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
    Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
    Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
    Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer.
    Li H; Li W; Qi C; Zhou L; Wen F; Qu Y; Yu H
    Front Oncol; 2021; 11():726613. PubMed ID: 34760692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
    J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-brain Radiotherapy With or Without a Simultaneous Integrated Boost for Treatment of Brain Metastases.
    Rades D; Johannwerner L; Werner EM; Cremers F; Gliemroth J; Yu NY
    Anticancer Res; 2023 Jul; 43(7):3107-3112. PubMed ID: 37351983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases.
    Rades D; Janssen S; Bajrovic A; Khoa MT; Veninga T; Schild SE
    Radiat Oncol; 2017 Apr; 12(1):69. PubMed ID: 28438175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.
    Awad R; Fogarty G; Hong A; Kelly P; Ng D; Santos D; Haydu L
    Radiat Oncol; 2013 Mar; 8():62. PubMed ID: 23497418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases.
    Zhang K; Zhang T; Guo Z; Zhao F; Li J; Li Y; Li Y; Wu X; Chen X; Zhang W; Pang Q; Wang P
    BMC Cancer; 2023 Dec; 23(1):1240. PubMed ID: 38104068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.